Physician profile
Cale W Bonds
NPI 1104817493
$2,410.49
in general payments reported to CMS, 2019-2025
11 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,630 · 2020: $80.74 · 2022: $304 · 2023: $27.10 · 2024: $206 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $1,351.00 | 2019 | |
| Stryker Corporation | $179.43 | 2022-2023 | Gmrs |
| Innovation Technologies INC | $163.41 | 2025 | Irrisept |
| Encore Medical, LP | $159.45 | 2019 | |
| Depuy Synthes Sales INC. | $159.43 | 2019-2024 | |
| Becton, Dickinson and Company | $128.53 | 2022 | |
| Medical Device Business Services, INC. | $126.89 | 2020-2024 | Attune |
| Smith+Nephew, INC. | $72.29 | 2019 | |
| Radius Health, INC. | $31.91 | 2019 | |
| Microport Orthopedics INC | $23.19 | 2022 | |
| Zimmer Biomet Holdings, INC. | $14.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cale Bonds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.